Jpmorgan Chase & CO Alpha Teknova, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 609 shares of TKNO stock, worth $4,707. This represents 0.0% of its overall portfolio holdings.
Number of Shares
609
Previous 83
633.73%
Holding current value
$4,707
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TKNO
# of Institutions
35Shares Held
5.4MCall Options Held
0Put Options Held
0-
Balyasny Asset Management LLC Chicago, IL1MShares$7.73 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny737KShares$5.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$4.34 Million0.0% of portfolio
-
Roubaix Capital, LLC416KShares$3.22 Million1.33% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY366KShares$2.83 Million0.01% of portfolio
About Alpha Teknova, Inc.
- Ticker TKNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 28,080,500
- Market Cap $217M
- Description
- Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...